23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

Labubu maker Pop Mart shares fall as key ex-China sales data drop, Citi cuts price target

HS 21/08/2026

Bessent's efforts in the Treasury market so far haven't worked. Here's what else he can try

HS 20/08/2026

Bessent says there's a 'very good chance' U.S. budget deficit under Trump has peaked

HS 20/08/2026

You may have missed

Labubu maker Pop Mart shares fall as key ex-China sales data drop, Citi cuts price target

HS 21/08/2026

'Perfect storm' brews for global food supply this winter as grain prices soar

HS 20/08/2026

'Freeze seats for 25 years': Congress backs Vijay-led Tamil Nadu govt's delimitation stand

HS 20/08/2026

Stock futures are little changed after a steep sell-off sparked by a move back higher in Treasury yields: Live updates

HS 20/08/2026

Chinese humanoid robots' biggest obstacle: humans are still (mostly) better

HS 20/08/2026